Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 1, 2012, Pages 21-28

  Gasparini, Roberto ^a,b   Amicizia, Daniela ^a   Lai, Piero Luigi ^a,b   Panatto, Donatella ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b Interuniversity Research Centre on Influenza and Viral Infections (CIRI IV)   (Italy)

Author keywords

Burden; Economic impact; Influenza; Social impact

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; CAUSE OF DEATH; CLINICAL ASSESSMENT; COST OF ILLNESS; DRUG COST; GEOGRAPHIC DISTRIBUTION; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HONG KONG INFLUENZA; HOSPITALIZATION COST; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFLUENZA A (H5N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; MORTALITY; NONHUMAN; PANDEMIC INFLUENZA; REVIEW; SEASONAL INFLUENZA; SOCIOECONOMICS; SPANISH INFLUENZA;

EID: 84861801483     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.8.1.17622     Document Type: Review

References (91)

1. Thucydides. History of the Peloponnesian War. Thomas Hobbes, Ed. London. Bohn. 1843.
2. Nikiforuk A. Il quarto cavaliere, breve storia di epidemie pestilenze e virus. Italian Edition, Arnoldo Mondadori Editore, Milano (Italy) 2008. Original title: The Fourth Horseman, translation by Elena Sciarra.
3. Potter CW. A history of influenza. J Appl Microbiol 2001; 91:572-9; PMID:11576290; http://dx.doi.org/10.1046/j.1365-2672.2001.01492.x
4. Doyle P. 1918 Flu Hemorrhagic Symptoms Similar To Ebola. Available at: http://www.rense.com/general63/ebola.htm. Accessed on June 23, 2011.
5. Dale RC, Church AJ, Surtees RA, Lees AJ, Adcock JE, Harding B, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 2004; 127:21-33; PMID:14570817; http://dx.doi.org/10.1093/ brain/awh008
6. Vilensky JA, Foley P, Gilman S. Children and encephalitis lethargica: a historical review. Pediatr Neurol 2007; 37:79-84; PMID:17675021; http://dx.doi.org/10.1016/j.pediatrneurol.2007.04.012
7. ESWI-FLUCENTRE. Pandemics in the 20th century. Available at: http://www.flucentre.org/knowledge-centre/pandemic-flu/pandemics-in-the-20th- century. Accessed on June 23, 2011.
8. World Health Organization. Influenza (Seasonal) Available at: http://www.who.int/mediacentre/factsheets/fs211/en/. Accessed on February 13, 2010.
9. Dushoff J, Plotkin JB, Viboud C, Earn DJ, Simonsen L. Mortality due to Influenza in the United States - An Annualized Regression Approach Using Multiple-Cause Mortality Data. Am J Epidemiol 2006; 163:181-7; PMID:16319291; http://dx.doi.org/10.1093/aje/kwj024
10. Steenhuysen J. CDC backs away from decades-old flu death estimate. Reuters 2010. Available at: http://www.reuters.com/article/ idUSTRE67P3NA20100826. Accessed on September 13, 2010.
11. Centers for Disease Control and Prevention. Influenza Symptoms. Available at: http://www.cdc.gov/flu/symptoms.htm. Accessed on April 28, 2009.
12. Hilleman MR. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 2002; 20:3068-87; PMID:12163258; http://dx.doi.org/10.1016/S0264-410X(02)00254-2
13. Hayden FG. Prevention and treatment of influenza in immunocompromised patients. Am J Med 1997; 102:55-60; PMID:10868144; http://dx.doi.org/10.1016/ S0002-9343(97)80013-7
14. Angelo SJ, Marshall PS, Chrissoheris MP, Chaves AM. Clinical characteristics associated with poor outcome in patients acutely infected with Influenza A. Conn Med 2004; 68:199-205; PMID:15095826
15. Kolata G. FLU - The story of the Great Influenza Pandemic of 1918 and the Search for the Virus That Caused it. Simon & Schuster - New York - 1999.
16. Olsen GW, Burris JM, Burlew MM, Steinberg ME, Patz NV, Stoltzfus JA, et al. Absenteeism among employees who participated in a workplace influenza immunization program. J Occup Environ Med 1998; 40:311-6; PMID:9571521; http://dx.doi.org/10.1097/00043764-199804000-00004
17. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000; 284:1655-63; PMID:11015795; http://dx.doi.org/10.1001/jama.284.13.1655
18. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086-96; PMID:17544181; http://dx.doi.org/10.1016/j.vaccine.2007.03.046
19. Nichol KL, Mallon KP, Mendelman PM. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine 2003; 21:2207-17; PMID:12706712; http://dx.doi.org/10.1016/S0264-410X(03)00029-X
20. Campbell DS, Rumley MH. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med 1997; 39:408-14; PMID:9172085; http://dx.doi.org/10.1097/00043764-199705000-00006
21. CDC (ACIP). Prevention and Control of Influenza with Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2010; 59:1-66.
22. Mullooly JP, Bridges CB, Thompson WW, Chen J, Weintraub E, Jackson LA, et al. Influenza- and RSV-associated hospitalizations among adults. Vaccine 2007; 25:846-55; PMID:17074423; http://dx.doi.org/10.1016/j.vaccine.2006.09.041
23. Wilschut JC, McElhaney JE, Palache AM. Influenza. Second Edition Mosby-Elsevier Editor. China 2006.
24. Levy E. French economic evaluations of influenza and influenza vaccinations. Pharmacoeconomics 1996; 9:62-6; PMID:10160489; http://dx.doi.org/10.2165/00019053-199600093-00014
25. Excite - Finanza. L'Euro perde il suo potere d'acquisto. Meglio la Lira. Available at: http://finanza.excite.it/perde-il-potere-dacquisto-leuro-N62518. html. Accessed on July 3rd, 2011.
26. Keech M, Scott AJ, Ryan PJ. The impact of influenza and influenza-like illness on productivity and healthcare resource in a working population. Occup Med (Lond) 1998; 48:85-90; PMID:9614766; http://dx.doi.org/10.1093/occmed/48.2. 85
27. Szucs TD. Influenza - The Role of Burden-of-Illness Research. Pharmacoeconomics 1999; 16:27-32; PMID:10623373; http://dx.doi.org/10.2165/ 00019053-199916001-00004
28. Kumpulainen V, Mäkelä M. Influenza vaccination among healthy employees: a cost-benefit analysis. Scand J Infect Dis 1997; 29:181-5; PMID:9181656; http://dx.doi.org/10.3109/00365549709035881
29. Szucs TD. Medical economics in the field of influenza - past, present and future. Virus Res 2004; 103:25-30; PMID:15163484; http://dx.doi.org/10.1016/j. virusres.2004.02.008
30. Xue Y, Kristiansen IS, de Blasio BF. Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave. BMC Public Health 2010; 10:724; PMID:21106057; http://dx.doi.org/10.1186/1471-2458-10-724
31. Gasparini R, Pozzi T, Bonanni P, Fragapane E, Montomoli E, Lucioni C. Valutazione dei costi di un'epidemia influenzale nella popolazione lavorativa di Siena. Giornale Farmacoeconomia 2000; 4:3-9.
32. Gasparini R, Lucioni C, Lai P, De Luca S, Durando P, Sticchi L, et al. Influenza Surveillance in the Italian Region of Liguria in the winter of 1999-2000 by general practitioners and pediatrician: socio-economic implications. J Prev Med Hyg 2001; 42:83-6.
33. Colombo GL, Nicosia V, Lesma A, Madera A, Caruggi M, Serra G. Analisi costi-benefici di una strategia vaccinale antinfluenzale condotta presso una società del gruppo ENI (Snamprogetti). PharmacoEconomics-Italian Research Articles 2001; 3:71-80. (Pubitemid 33706596)
34. Lucioni C. Costi benefici della vaccinazione. Vaccinazione 2000; 1995:31-7.
35. Gasparini R, Lucioni C, Ansaldi F, Durando P, Sticchi L, Icardi G, et al. Studio costo-efficacia della vaccinazione influenzale per gli italiani di età compresa tra 50 e 64 anni. Pharmacoeconomics Italian Research Articles 2007; 9:91-101. (Pubitemid 47472762)
36. Aballéa S, Chancellor J, Martin M, Wutzler P, Carrat F, Gasparini R, et al. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years; an international model. Value Health 2007; 10:98-116; PMID:17391419; http://dx.doi.org/10.1111/j.1524-4733.2006.00157.x
37. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86; PMID:12517228; http://dx.doi.org/10.1001/ jama.289.2.179
38. Stephenson I, Zambon M. The epidemiology of Influenza. Occup Med (Lond) 2002; 52:241-7; PMID:12181371; http://dx.doi.org/10.1093/occmed/52.5.241
39. Gasparini R, Lucioni C, Lai P, Maggioni P, Sticchi L, Durando P, et al. Valutazione costi-benefici della vaccinazione antinfluenzale negli anziani in Liguria. Pharmacoeconomics - Italian research Articles 2003; 5:25-30.
40. Lai PL, Panatto D, Ansaldi F, Canepa P, Amicizia D, Patria AG, et al. Burden of the 1999-2008 seasonal influenza epidemics in Italy - Comparison with the H1N1v (A/California/07/09) pandemic. Hum Vaccin 2011; 7:217-25; PMID:21922688; http://dx.doi.org/10.4161/hv.7.0.14607
41. Simonsen L, Clarke MJ, Chonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178:53-60; PMID:9652423
42. Grove RD, Hetzel AM. Vital statistics rates in the United States: 1940-1960. Washington: US Government Printing Office, 1968.
43. Taubenberger JK, Morens DM. 1918 Influenza: the Mother of All Pandemics. Emerg Infect Dis 2006; 12:15-22; PMID:16494711
44. Tognotti E. La "Spagnola" in Italia. Franco Angeli-Storia Editor, Milano 2002.
45. Henderson DA, Courtney B, Inglesby TV, Toner E, Nuzzo JB. Public Health and Medical Response to the 1857-58 Influenza Pandemic. Biosecur Bioterror 2009; 7:265-73; PMID:19656012; http://dx.doi.org/10.1089/bsp.2009.0729
46. US Congressional Budget Office. A Potential Influenza Pandemic: Possible Macroeconomic Effects and Policy Issues. 2005. Revised July 27, 2006.
47. Department of Finance. Canada. The Economic Impact of an Influenza Pandemic. Working Paper 2004-2007. December 12, 2006. Available at: http://dsp-psd.pwgsc.gc.ca/collection-2008/fin/F21-8-2007-4E.pdf.
48. Fukumi H. Summary Report on the Asian Influenza Pandemic in Japan, 1957. Bull Wdl Hlth Org 1959; 20:187-98.
49. Menon IGK. The 1957 Pandemic of Influenza in India. Bull World Health Organ 1959; 20:199-224; PMID:13651910
50. Przesmycki F, Sawicki L, Dobrowolska H, Grzelakowa A, Zanski J, Stasik M, et al. The Epidemic of Asian Influenza in Poland. Bull World Health Organ 1959; 20:225-39; PMID:13651911
51. Zhandov VM. Results of further research on Influenza in the USSR. Bull Wdl Hlth Org 1959; 20:261-96.
52. Berke Z. The Asian Influenza Pandemic in Turkey, 1957-58. Bull World Health Organ 1959; 20:494-8; PMID:13651929
53. Bozzo A, Addis S, Pintus L. Osservazioni e ricerche sulla recente epidemia di influenza Asiatica a Sassari. Ig Mod 1958; 51:3-14.
54. U.S. Department of Health and Human Services. Pandemics and Pandemic Threats since 1900. Available at: http://www.pandemicflu.gov/general/ historicaloverview.html. Accessed on 1st July, 2011.
55. Cockburn WC, Delon PJ, Ferreira W. Origin and progress of the 1968-69 Hong Kong influenza epidemic. Bull World Health Organ 1969; 41:345-8; PMID:5309437
56. Longini IM, Jr., Fine PE, Thacker SB. Predicting the global spread of new infectious agents. Am J Epidemiol 1986; 123:383-91; PMID:3946385
57. Miller DL, Pereira MS, Clarke M. Epidemiology of the Hong Kong- 68 variant of influenza A2 in Britain. BMJ 1971; 1:475-9; PMID:5101353; http://dx.doi.org/10.1136/bmj.1.5747.475
58. Stuart-Harris CH. Pandemic influenza: an unresolved problem in prevention. J Infect Dis 1970; 122:108-15; PMID:4914941; http://dx.doi.org/10. 1093/infdis/122.1-2.108
59. Viboud C, Grais RF, Lafont BAP, Miller MA, Simonsen L. Multinational Impact of the 1968 Hong Kong Influenza Pandemic: Evidence for a Smoldering Pandemic. J Infect Dis 2005; 192:233-48; PMID:15962218
60. Kumar A, Zarychanski R, Pinto R, Menon K, Rodin R, Choong K, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009; 302:1872-9; PMID:19822627; http://dx.doi.org/10.1001/jama.2009.1496
61. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de La Torre A, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009; 302:1880-7; PMID:19822626; http://dx.doi.org/10.1001/jama.2009.1536
62. Lee EH, Wu C, Lee EU, Stoute A, Hanson H, Cook HA, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York City. Clin Infect Dis 2010; 50:1498-504; PMID:20420514; http://dx.doi.org/10.1086/652446
63. CDC. FluView: week ending May 20, 2010. Available at http://www.cdc.gov/ flu/weekly. Accessed July 12, 2010.
64. Mauad T, Hajjar LA, Callegari GD, da Silva LF, Schout D, Galas FR, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010; 181:72-9; PMID:19875682; http://dx.doi.org/10.1164/rccm. 200909-1420OC
65. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009; 302:1896-902; PMID:19887665; http://dx.doi.org/10.1001/jama.2009.1583
66. Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A (H1N1) disease. PLoS ONE 2010; 5:e9694; PMID:20300571; http://dx.doi.org/10.1371/journal.pone.0009694
67. CDC. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR 2009; 58:749-52; PMID:19609249
68. Louie JK, Acosta M, Jamieson DJ, Honein MA &California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010; 362:27-35; PMID:20032319; http://dx.doi.org/10.1056/NEJMoa0910444
69. Harris J. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAMA 1919; 72:978-80.
70. Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959; 78:1172-5; PMID:13824729
71. Naleway AL, Smith WJ, Mullooly JP. Delivering influenza vaccine to pregnant women. Epidemiol Rev 2006; 28:47-53; PMID:16731574; http://dx.doi.org/10.1093/epirev/mxj002
72. Widelock D, Csizmas L, Klein S. Influenza, pregnancy, and fetal out- come. Public Health Rep 1963; 78:1-11; PMID:14000477; http://dx.doi.org/10.2307/ 4591714
73. Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest 1959; 38:213-65; PMID:13620784; http://dx.doi.org/10. 1172/JCI103791
74. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451-8; PMID:19643469; http://dx.doi.org/10.1016/S0140- 6736(09)61304-0
75. MMWR. 2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care - New York City, 2009. MMWR 2010; 59:321-6; PMID:20339343
76. Creanga AA, Johnson TF, Graitcer SB, Hartman LK, Al-Samarrai T, Schwarz AG, et al. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol 2010; 115:717-26; PMID:20308830; http://dx.doi.org/10.1097/AOG.0b013e3181d57947
77. Irving WL, James DK, Stephenson T, Laing P, Jameson C, Oxford JS, et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and sero-epidemiological study. BJOG 2000; 107:1282-9; PMID:11028582; http://dx.doi.org/10.1111/j.1471-0528.2000.tb11621.x
78. Kirshon B, Faro S, Zurawin RK, Samo TC, Carpenter RJ. Favorable outcome after treatment with amantadine and ribavirin in a pregnancy complicated by influenza pneumonia. A case report. J Reprod Med 1988; 33:399-401; PMID:3367344
79. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148:1094-102; PMID:9850132
80. Schoenbaum SC, Weinstein L. Respiratory infection in pregnancy. Clin Obstet Gynecol 1979; 22:293-300; PMID:466875; http://dx.doi.org/10.1097/ 00003081-197906000-00006
81. Shahab S, Glezen W. Influenza virus. In: Gonik B, ed. Viral diseases in pregnancy. New York, NY: Springer-Verlag; 1994:215-23.
82. Kort BA, Cefalo RC, Baker VV. Fatal influenza A pneumonia in pregnancy. Am J Perinatol 1986; 3:179-82; PMID:3718637; http://dx.doi.org/10.1055/s-2007- 999862
83. Mullooly JP, Barker WH, Nolan TF, Jr. Risk of acute respiratory disease among pregnant women during influenza A epidemics. Public Health Rep 1986; 101:205-11; PMID:3083477
84. Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, et al. Impact of Influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007; 176:463-8; PMID:17296958; http://dx.doi.org/10.1503/cmaj.061435
85. Hartert TV, Neuzil KM, Shintani AK, Mitchel EF, Jr., Snowden MS, Wood LB, et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol 2003; 189:1705-12; PMID:14710102; http://dx.doi.org/10.1016/S0002-9378(03)00857-3
86. Griffiths PD, Ronalds CJ, Heath RB. A prospective study of influenza infections during pregnancy. J Epidemiol Community Health 1980; 34:124-8; PMID:7400724; http://dx.doi.org/10.1136/jech.34.2.124
87. Szucs T. The socio-economic burden of influenza. J Antimicrob Chemother 1999; 44:11-5; PMID:10877457; http://dx.doi.org/10.1093/jac/44.suppl-2.11
88. European Centre for Disease Prevention and Control. Factsheet for the general public on seasonal influenza. Available at: http:// ecdc.europa.eu/en/ healthtpoics/seasonal-influenza/basic-facts/Pages/factsheet-general-public.aspx. Accessed on June 3, 2011.
89. Congress of US Office of Technology Assessment. Cost Effectiveness of Influenza Vaccination. Washington, DC: US Printing Office, 1981:1-67.
90. Mauskopf JA, Cates SC, Griffin AD. A Pharmacoeconomic model for the treatment of Influenza. Pharmacoeconomics 1999; 16:73-84; PMID:10623380; http://dx.doi.org/10.2165/00019053-199916001-00010
91. Sharrar RG. National Influenza Experience. Bull World Health Organ 1969; 41:361-6; PMID:5309440